Cardinal Health Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 8/18/2026)
| Balance Sheet | Total Assets | 57,299,000,000.00 | ROE | -5.03 % |
| Balance Sheet | Total Equity | -2,883,000,000.00 | ROA | 2.99 % |
| Cashflow | Capital Expenditures | -649,000,000.00 | P/FCF | 12.98 |
| Cashflow | Free Cash Flow | 4,525,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 5,174,000,000.00 | P/CF | 11.35 |
| Income | Earnings per Share (diluted) | 7.23 | Div. Yield | 0.84 % |
| Income | Net Income | 1,714,000,000.00 | P/E | 34.27 |
| Income | Shares Outstanding | 237,000,000.00 | P/B | -20.37 |
| Income | Total Revenue | 254,248,000,000.00 | P/S | 0.23 |
Ratios calculated on: 10/14/2026
Company Description
Cardinal Health, Inc. is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company operated in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, and consumer products through its pharmaceutical distribution business to retailers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, surgery centers, laboratories, physician offices and other healthcare providers. Effective March 18, 2013, it merged with AssuraMed Holding Inc.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.cardinalhealth.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more